KRISCZAR BUNGAY: Open Payments
NPI 1942277660 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$80,921 in 180 payments from 13 companies in 2025. Trend: 2023 $111,946 · 2024 $96,201 · 2025 $80,921
Speaker / faculty: $67,770Food & beverage: $6,850Travel & lodging: $5,056Consulting: $1,245
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 67 | $44,431 |
| Gilead Sciences, Inc. | 73 | $33,650 |
| Shionogi Inc | 1 | $1,245 |
| ABBVIE INC. | 14 | $611 |
| Axsome Therapeutics, Inc. | 9 | $442 |
| Merck Sharp & Dohme LLC | 5 | $167 |
| Globus Medical, Inc. | 1 | $119 |
| Otsuka America Pharmaceutical, Inc. | 3 | $66 |
| Exact Sciences Corporation | 2 | $62 |
| Lundbeck LLC | 2 | $50 |
Products named: CABENUVA, DOVATO, Biktarvy, APRETUDE, Yeztugo, Descovy, S-217622, VRAYLAR.
Industry payments across NY — which companies pay providers there.
